查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1784114

全球自我检测市场

Self-Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球自我检测市场规模将达到 197 亿美元

全球自检市场规模预计在2024年达到123亿美元，预计2024年至2030年期间的复合年增长率为8.1%，到2030年将达到197亿美元。套件是本报告分析的细分市场之一，预计其复合年增长率为7.6%，到分析期结束时规模将达到114亿美元。设备细分市场在分析期间内的复合年增长率预计为9.3%。

美国市场预计将达到 32 亿美元，中国市场复合年增长率将达到 7.9%

美国自我检测市场规模预计2024年将达到32亿美元。作为世界第二大经济体，中国预计在2030年市场规模将达到32亿美元，2024年至2030年的复合年增长率为7.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为7.4%和7.0%。在欧洲，预计德国的复合年增长率约为6.6%。

全球自我检测市场－主要趋势与驱动因素摘要

自测市场为何如此热门？

随着消费者寻求更便利、私密、快速的健康管理诊断方案，自我检测市场正经历显着成长。预防性医疗意识的不断增强，以及用于检测感染疾病、不孕症、胆固醇、维生素缺乏症等疾病的家用检测套组的普及，正在推动市场需求。新冠肺炎疫情加速了自我检测的普及，快速家用抗原检测和 PCR 检测日益普及。诊断技术的进步提高了自我检测套件的准确性和易用性，使人们无需频繁就医即可及早发现健康状况。此外，远端医疗服务的兴起将自我检测进一步融入数位医疗生态系统，实现远距咨询和治疗提案。

哪些技术创新使得自我检测试剂套件更有效？

诊断领域的最新创新利用微流体、生物感测器和人工智慧 (AI)，显着提高了自我检测设备的准确性和易用性。实验室晶片技术实现了紧凑、经济高效的检测解决方案，能够从少量血液、唾液和尿液样本中进行精确的生化分析。具有蓝牙和智慧型手机连接功能的智慧自检套件可以即时追踪检测结果，使用户能够立即与医疗保健提供者共用资料。基于人工智慧的影像识别的整合进一步增强了横向流动测试的解释能力，并降低了使用者出错的风险。此外，基于呼吸的血糖监测仪和基于唾液的基因检测等非侵入性自检方法的进步正在扩大家用诊断的覆盖范围。

哪些医疗保健垂直领域将推动自我检测市场的成长？

自测试剂套件正广泛应用于多个医疗保健领域，包括传染病筛检、慢性病管理和个人化医疗。糖尿病领域是自测设备的最大消费者之一，其中连续血糖监测 (CGM) 系统和血糖值试纸对于日常疾病管理至关重要。女性健康领域也不断发展，生育和妊娠检测套组也变得越来越先进，普及程度也越来越高。诸如血统和基于 DNA 的健康风险评估等基因自测的兴起，进一步扩大了消费者对家用诊断产品的兴趣。此外，对预防性医疗保健的日益关注，也推动了对胆固醇、心血管风险评估、肠道微生物组分析等自测解决方案的需求。

哪些因素推动了自我测验市场的成长？

自我检测市场的成长受到多种因素的推动，包括健康意识的增强、向预防性医疗保健的转变以及诊断技术的改进。电子商务和直接面向消费者 (DTC) 医疗保健品牌的扩张使全球消费者更容易获得自我检测套件。政府对家用诊断设备的核准和报销政策的改进进一步推动了市场扩张。远端医疗和数位健康平台的整合也在推动对自我检测套件的需求。自我检测试剂套件可实现远端患者监控，减轻医疗机构的负担。随着自我检测技术的不断发展，它提供了更个人化和高效的医疗保健解决方案，进一步扩大了市场。

部分

产品（套件、设备、试纸）；样本（血液、尿液、粪便等）；应用（血压测试、糖尿病/血糖值测试、胆固醇/三酸甘油酯测试、怀孕测试、性病测试、尿道感染测试、癌症检查、乳糜泻测试、甲状腺测试、转氨酶测试、贫血测试、过敏测试等）

受访公司范例

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech（Hangzhou）Co., Ltd.
  • Becton, Dickinson and Company（BD）
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP32896

Global Self-Testing Market to Reach US$19.7 Billion by 2030

The global market for Self-Testing estimated at US$12.3 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$11.4 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 7.9% CAGR

The Self-Testing market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Self-Testing Market - Key Trends & Drivers Summarized

Why Is The Self-Testing Market Gaining Popularity?

The self-testing market is witnessing significant growth as consumers seek more convenient, private, and rapid diagnostic solutions for managing their health. The increasing awareness of preventive healthcare, along with the expansion of home-based testing kits for infectious diseases, fertility, cholesterol, and vitamin deficiencies, is driving market demand. The COVID-19 pandemic accelerated the adoption of self-testing, with at-home rapid antigen and PCR tests becoming widely available. With advancements in diagnostic technology, self-testing kits are becoming more accurate and user-friendly, enabling early detection of health conditions without the need for frequent hospital visits. Additionally, the rise of telehealth services is further integrating self-testing into digital healthcare ecosystems, allowing for remote consultation and treatment recommendations.

What Innovations Are Enhancing The Effectiveness Of Self-Testing Kits?

Recent innovations in microfluidics, biosensors, and artificial intelligence (AI)-powered diagnostics are significantly improving the accuracy and usability of self-testing devices. Lab-on-a-chip technology is enabling compact and cost-effective testing solutions, allowing for precise biochemical analysis from a small sample of blood, saliva, or urine. Smart self-testing kits equipped with Bluetooth and smartphone connectivity are allowing real-time tracking of test results, enabling users to share data with healthcare providers instantly. The integration of AI-based image recognition is further enhancing the interpretation of lateral flow tests, reducing the risk of user error. Additionally, advancements in non-invasive self-testing methods, such as breath-based glucose monitors and saliva-based genetic testing, are expanding the scope of home diagnostics.

Which Healthcare Segments Are Driving The Growth Of The Self-Testing Market?

Self-testing kits are becoming widely adopted across multiple healthcare sectors, including infectious disease screening, chronic disease management, and personalized medicine. The diabetes sector remains one of the largest consumers of self-testing devices, with continuous glucose monitoring (CGM) systems and blood sugar test strips being essential for daily disease management. The women’s health segment is also experiencing growth, with fertility and pregnancy test kits becoming more advanced and widely available. The rise of genetic self-testing, including ancestry and DNA health risk assessments, is further expanding consumer interest in at-home diagnostics. Additionally, the growing focus on preventive healthcare is increasing demand for self-testing solutions for cholesterol, cardiovascular risk assessment, and gut microbiome analysis.

What Factors Are Fueling The Growth Of The Self-Testing Market?

The growth of the self-testing market is driven by several factors, including increased health awareness, the shift toward preventive healthcare, and improvements in diagnostic technology. The expansion of e-commerce and direct-to-consumer (DTC) healthcare brands is making self-testing kits more accessible to consumers worldwide. Government approvals for at-home diagnostic devices, along with improved reimbursement policies, are further supporting market expansion. The integration of telemedicine and digital health platforms is also driving demand for self-testing kits, as they enable remote patient monitoring and reduce the burden on healthcare facilities. As self-testing technology continues to evolve, the market is expected to expand, offering more personalized and efficient healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Self-Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Devices, Strips); Sample (Blood, Urine, Stool, Others); Application (Blood Pressure Test, Diabetes & Glucose Tests, Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Becton, Dickinson and Company (BD)
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Self-Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Convenient and At-Home Health Solutions Drives Growth in Self-Testing Products
    • The Rise of Chronic Disease Management and Preventative Healthcare Expands Market Opportunity for Self-Testing Solutions
    • Surge in Consumer Awareness of Health and Wellness Drives Adoption of Self-Testing Kits for Home Use
    • Technological Advancements in Diagnostics and Testing Devices Propel Market Growth for Self-Testing Products
    • Growing Preference for Privacy and Confidentiality in Health Management Strengthens the Demand for Self-Testing Solutions
    • The Expansion of Remote Healthcare and Telemedicine Services Creates New Opportunities for Self-Testing Products
    • Increasing Regulatory Approvals and Standards for Self-Testing Devices Accelerates Consumer Confidence and Market Growth
    • The Growth of the Wellness and Fitness Sector Strengthens the Adoption of Self-Testing for Health Metrics
    • Rising Healthcare Costs Drive Demand for Affordable, At-Home Testing Solutions for Chronic Conditions
    • Increasing Investment in Digital Health and Mobile Health Apps Expands the Role of Self-Testing in Remote Monitoring
    • Consumer Demand for Real-Time, Actionable Health Data Drives the Growth of Self-Testing Kits in Multiple Market Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Self-Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cholesterol & Triglycerides Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cholesterol & Triglycerides Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pregnancy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pregnancy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for STD Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for STD Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinary Tract Infection Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Urinary Tract Infection Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cancer Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cancer Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Celiac disease Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Celiac disease Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Thyroid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Thyroid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Transaminase Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Transaminase Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anemia Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Anemia Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Allergy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Allergy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Pressure Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Blood Pressure Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Diabetes & Glucose Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Diabetes & Glucose Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Stool by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Stool by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • JAPAN
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CHINA
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • EUROPE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • FRANCE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • GERMANY
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • UNITED KINGDOM
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Asia-Pacific 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 112: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of World 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of World 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030

IV. COMPETITION